Colon Cancer Treatment: Neo-Adjuvant Chemotherapy for Seniors

We are studying whether a 6-week chemotherapy treatment before surgery helps older adults with resectable colon cancer live longer and stay disease-free. This trial aims to personalize treatment for patients aged 70 and older.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Fluorouracil
Fluorouracil is a substance used to treat cancer by stopping the growth of cancer cells.
Folinic Acid
Folinic acid is a substance that helps restore folate levels and protects healthy cells during certain chemotherapy treatments.
Oxaliplatin
Oxaliplatin is a substance used in chemotherapy to treat colorectal and other cancers by killing cancer cells.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier d'Abbeville
Oncology
Abbeville, France
Centre Hospitalier Universitaire Amiens Picardie
Hepatogastroenterology
Amiens, France
Hôpital Privé Arras Les Bonnettes
Oncology
Arras, France

Sponsor: Centre Hospitalier Universitaire De Dijon
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.